Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leire Arbea

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 7, 2023
Impact of perineural invasion on the outcome of patients with synchronous colorectal liver metastases treated with neoadjuvant chemotherapy and surgeryGabriel Zozaya, Javier Álvarez Cienfuegos, Pablo Martí-Cruchaga, et al.
Journal of Translational Medicine|January 15, 2013
Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapyEduardo Castañon, Joaquim Bosch-Barrera, Inés López, et al.
Nurse Education in Practice|November 7, 2025
Spanish translation, cultural adaptation and validation of the Person-Centred Practice Inventory-Student (PCPI-ST): A tool for advancing person-centred care educationVirginia La Rosa-Salas, Leire Arbea Moreno, Marta Lizarbe-Chocarro, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|August 15, 2024
Current landscape of gastrointestinal radiation oncology in Spain: a multicenter real-life survey and comparison with key clinical guidelinesOvidio Hernando-Requejo, Maria Victoria Torres Olombrada, Irene Alda Bravo, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Phase I-II trial of concurrent capecitabine and oxaliplatin with preoperative intensity-modulated radiotherapy in patients with locally advanced rectal cancerJosé Javier Aristu, Leire Arbea, Javier Rodriguez, et al.
Anales Del Sistema Sanitario De Navarra|August 18, 2023
[Translation and transcultural adaptation of the Person-Centred Practice Inventory Staff (PCPI-S) for health professionals in Spain]Begoña Errasti-Ibarrondo, Virginia La Rosa-Salas, Marta Lizarbe-Chocarro, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 11, 2023
Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinomaAnna Vilalta-Lacarra, Azucena Aldaz, Pablo Sala-Elarre, et al.
Plos One|May 10, 2019
Neoadjuvant therapy for locally advanced gastric cancer patients. A population pharmacodynamic modelingPatricia Martin-Romano, Belén P Solans, David Cano, et al.
Plos One|June 7, 2019
Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experiencePaola Anna Jablonska, Ricardo Diez-Valle, Jaime Gállego Pérez-Larraya, et al.
Plos One|July 9, 2019
Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experiencePaola Anna Jablonska, Ricardo Diez-Valle, Jaime Gállego Pérez-Larraya, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 7, 2023
Impact of perineural invasion on the outcome of patients with synchronous colorectal liver metastases treated with neoadjuvant chemotherapy and surgeryGabriel Zozaya, Javier Álvarez Cienfuegos, Pablo Martí-Cruchaga, et al.
Journal of Translational Medicine|January 15, 2013
Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapyEduardo Castañon, Joaquim Bosch-Barrera, Inés López, et al.
Nurse Education in Practice|November 7, 2025
Spanish translation, cultural adaptation and validation of the Person-Centred Practice Inventory-Student (PCPI-ST): A tool for advancing person-centred care educationVirginia La Rosa-Salas, Leire Arbea Moreno, Marta Lizarbe-Chocarro, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|August 15, 2024
Current landscape of gastrointestinal radiation oncology in Spain: a multicenter real-life survey and comparison with key clinical guidelinesOvidio Hernando-Requejo, Maria Victoria Torres Olombrada, Irene Alda Bravo, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Phase I-II trial of concurrent capecitabine and oxaliplatin with preoperative intensity-modulated radiotherapy in patients with locally advanced rectal cancerJosé Javier Aristu, Leire Arbea, Javier Rodriguez, et al.
Anales Del Sistema Sanitario De Navarra|August 18, 2023
[Translation and transcultural adaptation of the Person-Centred Practice Inventory Staff (PCPI-S) for health professionals in Spain]Begoña Errasti-Ibarrondo, Virginia La Rosa-Salas, Marta Lizarbe-Chocarro, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 11, 2023
Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinomaAnna Vilalta-Lacarra, Azucena Aldaz, Pablo Sala-Elarre, et al.
Plos One|May 10, 2019
Neoadjuvant therapy for locally advanced gastric cancer patients. A population pharmacodynamic modelingPatricia Martin-Romano, Belén P Solans, David Cano, et al.
Plos One|June 7, 2019
Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experiencePaola Anna Jablonska, Ricardo Diez-Valle, Jaime Gállego Pérez-Larraya, et al.
Plos One|July 9, 2019
Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experiencePaola Anna Jablonska, Ricardo Diez-Valle, Jaime Gállego Pérez-Larraya, et al.
Pageof 5